| # | Drug | Count |
|---|---|---|
| 0 | TOPIRAMATE | 34 |
| 1 | LAMOTRIGINE | 30 |
| 2 | LAMOTIRIGINE | 23 |
| 3 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 23 |
| 4 | LAMOTRIGINE EXTENDED-RELEASE | 23 |
| 5 | RITONAVIR | 16 |
| 6 | RITONAVIR 100 MG | 14 |
| 7 | ZIDOVUDINE | 14 |
| 8 | ATAZANAVIR | 12 |
| 9 | FOLIC ACID | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MULTI-VITAMIN/MINERAL SUPPLEMENT WITH SODIUM ASCORBATE, CHOLECALCIFEROL, DI-ALPHA-TOCOPHERYL ACETATE, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HCL, FOLIC ACID, CYANOCOBALAMIN, CALCIUM FORMATE, CALCIUM CARBONATE, FERROUS (II) BIS-GLYCINATE CHELATE, POTASSIUM IODIDE, ZINC OXIDE, AND CHOLINE BITARTRATE | 1 | 0.1429 |
| 1 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 1 | 0.0023 |
| 2 | BALSALAZIDE DISODIUM | 1 | 0.0019 |
| 3 | ZIDOVUDINE | 14 | 0.0014 |
| 4 | RITONAVIR 100 MG | 14 | 0.0009 |
| 5 | ATAZANAVIR | 12 | 0.0008 |
| 6 | SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM | 1 | 0.0007 |
| 7 | TOPIRAMATE | 34 | 0.0007 |
| 8 | LAMIVUDINE AND ZIDOVUDINE | 5 | 0.0006 |
| 9 | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 16 | 0.0004 |
| 1 | Oxytocic [EPC] | 1 | 0.0003 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 17 | 0.0003 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 13 | 0.0003 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 23 | 0.0002 |
| 5 | Nitrofuran Antibacterial [EPC] | 3 | 0.0002 |
| 6 | Progesterone [EPC] | 4 | 0.0002 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 8 | Anti-epileptic Agent [EPC] | 32 | 0.0001 |
| 9 | Mood Stabilizer [EPC] | 30 | 0.0001 |